EXPERIMENTAL
General Experimental Procedures. Optical rotations were measured on a JASCO P-1020 digital polarimeter.
IR spectra were obtained on a Nicolet 6700 spectrophotometer. UV spectra were recorded on a Beckman DU 640
spectrophotometer. NMR spectra were run on Bruker 400 MHz spectrometers using TMS as an internal standard. HR-ESI-MS
spectra were measured on a Q-TOF Ultima Global GAA076 LC mass spectrometer. Semipreparative high-performance liquid
chromatography (HPLC) was performed on an Agilent 1260 LC series with a DAD detector using an Agilent Eclipse
XDB-C18 column (250 × 9.4 mm, 5 μm) and (250 × 4.6 mm, 5 μm). Silica gel (Qing Dao Hai Yang Chemical Group Co.;
2
00–300 mesh) and octadecylsilyl silica gel (YMC; 50 μm) were used for column chromatography (CC). Precoated silica gel
plates (Yan Tai Zi Fu Chemical Group Co.; G60, F-254) were used for thin-layer chromatography (TLC).
Plant Material. The stems of Homalium stenophyllum were collected from JianFengLing Nature Reserve, Hainan
Province of China, inAugust 2015, and identified by Prof. Qiong-Xin Zhong, College of Life Science, Hainan Normal University.
Avoucher specimen (No. SONG20150818) has been deposited at the Key Laboratory of Tropical Medicinal Resource Chemistry
of Ministry of Education, Hainan Normal University.
Extraction and Isolation. The air-dried and powdered stems (20 kg) of H. stenophyllum were extracted with 95%
EtOH (3 × 20 L, 5 days each) at room temperature. The solvent was evaporated in vacuum to obtain a crude extract. After
suspension in water, the crude extract was extracted successively with petroleum ether and ethyl acetate. The ethyl acetate
extract (1000.0 g) was subjected to silica gel column chromatograph and eluted with petroleum ether–ethyl acetate (1:0–0:1),
yielding seven fractions (Frs.1–7). Fraction 7 (156.4 g) was subjected to RP-18 eluting with CH OH–H O (from 20% to
3
2
1
00%) to afford eight subfractions (Frs.7A–7H). Subfraction 7E (14.0 g) was purified using Sephadex LH-20 and eluted with
CH OH, then on a silica gel column chromatography and eluted with CHCl –CH OH, 10:1, to yield a new Subfr. 7E-1 (659 mg),
3
3
3
followed by semipreparative HPLC using an Agilent Eclipse XDB column with 30% CH CN–H O to afford 2 (10.2 mg) and
3
2
3
(20.1 mg). Subfraction 7E-3 (96 mg) followed by semipreparative HPLC using a Agilent Eclipse XDB column with 45%
CH OH–H O to obtain 1 (22.3 mg). Subfraction 7H (3.0 g) was purified using Sephadex LH-20 and eluted with CH OH, then
3
2
3
on a silica gel column chromatography and eluted with CHCl –CH OH, 10:1, to yield a new Subfr. 7H-2 (59 mg), followed
3
3
by semipreparative HPLC using aAgilent Eclipse XDB column with 40% CH CN–H O to obtain 4 (10.2 mg) and 5 (5.7 mg).
3
2
2
4
Homastenoside H (1). Yellow amorphous powder; [α] –45.4° (c 0.10, CH OH). UV (CH OH, λmax, nm) (log ε):
88 (3.00), 231 (3.10). IR (KBr, ν , cm ): 3440, 2930, 1755, 1602, 1520, 1487, 1136, 1064, 988. HR-ESI-MS m/z 627.2075
D
3
3
–
1
2
[
max
+
1
M + H] (calcd for C H O , 627.2072). H NMR (400 MHz, DMSO-d , δ, ppm, J/Hz): 2.90 (1H, dd, J = 11.6, 6.4,
32 35 13 6
H-6′′′β), 3.06 (1H, dd, J = 11.6, 2.0, H-6′′′α), 3.15 (1H, m, H-2′′′′), 3.31 (1H, m, H-5′′′), 3.66 (1H, m, H-2′′′), 3.71 (1H,
m, H-4′′′′), 3.79 (2H, br.s, H-5′′′′), 3.92 (1H, m, H-3′′′′), 4.38 (1H, d, J = 7.6, H-1′′′′), 4.51 (1H, d, J = 13.2, H-7β), 4.65 (1H,
d, J = 13.2, H-7α), 4.87 (1H, dd, J = 9.2, 8.8, H-4′′′), 5.13 (1H, d, J = 7.6, H-1′′′), 5.30 (1H, dd, J = 9.6, 9.2, H-3′′′), 7.04 (1H,
td, J = 8.0, 2.0, H-5), 7.15 (1H, dd, J = 8.0, 2.0, H-3), 7.23 (1H, td, J = 8.0, 2.0, H-4), 7.40 (1H, dd, J = 8.0, 2.0, H-6), 7.51 (1H,
td, J = 8.0, 2.0, H-3′′), 7.51 (1H, td, J = 8.0, 2.0, H-5′′), 7.56 (1H, td, J = 8.0, 2.0, H-3′), 7.56 (1H, td, J = 8.0, 2.0, H-5′), 7.63
(
8
1H, td, J = 8.0, 2.0, H-4′′), 7.65 (1H, td, J = 8.0, 2.0, H-4′), 7.86 (1H, dd, J = 8.0, 2.0, H-2′′), 7.86 (1H, dd, J = 8.0, 2.0, H-6′′),
1
3
.05 (1H, dd, J = 8.0, 2.0, H-2′), 8.05 (1H, dd, J = 8.0, 2.0, H-6′). C NMR (100 MHz, DMSO-d , δ, ppm): 131.6 (C-1), 154.2
6
(
C-2), 114.8 (C-3), 127.7 (C-4), 122.0 (C-5), 127.2 (C-6), 58.1 (C-7), 130.9 (C-1′), 129.4 (C-2′), 128.5 (C-3′), 133.1 (C-4′),
1
1
7
28.5 (C-5′), 129.4 (C-6′), 165.3 (C-7′), 130.3 (C-1′′), 129.4 (C-2′′), 128.3 (C-3′′), 132.7 (C-4′′), 128.3 (C-5′′), 129.4 (C-6′′),
65.2 (C-7′′), 100.6 (C-1′′′), 71.5 (C-2′′′), 76.1 (C-3′′′), 78.2 (C-4′′′), 67.5 (C-5′′′), 65.3 (C-6′′′), 104.0 (C-1′′′′), 71.3 (C-2′′′′),
6.5 (C-3′′′′), 75.1 (C-4′′′′), 59.4 (C-5′′′′).
2
4
Homastenoside I (2). White amorphous powder; [α] –72.1° (c 0.10, CH OH). UV (CH OH, λmax, nm) (log ε): 272
D
3
3
–
1
(
[
3.68), 218 (4.16). IR (KBr, ν , cm ): 3356, 2889, 1721, 1598, 1156, 1473,1277, 1065, 714. HR-ESI-MS m/z 569.1636
M + Na] (calcd for C H O Na, 569.1635). H NMR (400 MHz, DMSO-d , δ, ppm, J/Hz): 1.86 (2H, m, H-5′′), 1.90 (1H,
max
+
1
2
7
30 12
6
m, H-4′′β), 2.13 (1H, m, H-4′′α), 3.25 (1H, overlapped, H-6′′), 3.26 (1H, overlapped, H-2′′′), 3.30 (1H, m, H-3′′′), 3.66 (1H,
m, H-5′′′), 3.74 (1H, m, H-4′′′), 4.27 (1H, dd, J = 11.6, 6.4, H-6′′′β), 4.62 (1H, dd, J = 11.6, 2.0, H-6′′′α), 4.69 (1H, d,
J = 7.6, H-1′′′), 5.12 (2H, br.s, H-7), 5.55 (1H, d, J = 10.4, H-2′′), 5.79 (1H, d, J = 10.4, H-3′′), 6.46 (1H, dd, J = 8.8, 2.4, H-4),
6
.78 (1H, d, J = 2.4, H-6), 6.94 (1H, d, J = 8.8, H-3), 7.56 (1H, t, J = 8.0, H-3′), 7.56 (1H, t, J = 8.0, H-5′), 7.69 (1H, t, J = 8.0,
1
3
H-4′), 7.97 (1H, d, J = 8.0, H-2′), 7.97 (1H, d, J = 8.0, 2.0, H-6′). C NMR (100 MHz, DMSO-d , δ, ppm): 126.8 (C-1), 147.0
6
(
1
(
C-2), 117.1 (C-3), 114.4 (C-4), 152.6 (C-5), 114.6 (C-6), 61.0 (C-7), 129.7 (C-1′), 129.2 (C-2′), 128.7 (C-3′), 133.4 (C-4′),
28.7 (C-5′), 129.2 (C-6′), 165.5 (C-7′), 75.8 (C-1′′), 127.3 (C-2′′), 129.4 (C-3′′), 22.5 (C-4′′), 26.1 (C-5′′), 73.3 (C-6′′), 172.9
C-7′′), 102.2 (C-1′′′), 70.3 (C-2′′′), 76.3 (C-3′′′), 72.2 (C-4′′′), 73.7 (C-5′′′), 64.3 (C-6′′′).
665